Related references
Note: Only part of the references are listed.Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report
Hiroko Sato et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Impact of chemotherapy-induced enteric nervous system toxicity on gastrointestinal mucositis
Rachel M. McQuade et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2020)
A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide
Tao Liu et al.
MBIO (2019)
Cyclophosphamide-associated enteritis: A rare association with severe enteritis
Linda S. Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
A review of complementary therapies for chemotherapy induced gastrointestinal mucositis
Raja A. H. Kuchay
DRUG DISCOVERIES AND THERAPEUTICS (2016)
General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade - a single-center retrospective study
Juan Li et al.
CLINICAL RHEUMATOLOGY (2015)
Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
Diana Dan et al.
SWISS MEDICAL WEEKLY (2014)
The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study
Francesco Russo et al.
BMC CANCER (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency
Corine Ekhart et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens
U Emmenegger et al.
CANCER RESEARCH (2004)
Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency
M Haubitz et al.
KIDNEY INTERNATIONAL (2002)
Share Paper
